![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
Vale SA
VALE
Coinbase
COIN
US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 11.660
- +0.180+1.57%
Close Jan 24 16:00 ET
- 11.560
- -0.100-0.86%
Post 20:01 ET
631.79MMarket Cap-2.98P/E (TTM)
11.980High11.380Low1.24MVolume11.620Open11.480Pre Close14.50MTurnover2.33%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High1.24P/B620.53MFloat Cap1.42052wk Low--Dividend TTM53.22MShs Float137.610Historical High--Div YieldTTM5.23%Amplitude1.420Historical Low11.677Avg Price1Lot Size
Emergent BioSolutions Stock Forum
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...
88
27
3
$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Emergent BioSolutions (NYSE: EBS) has secured exclusive commercial rights to KLOXXADO® (naloxone HCl) Nasal Spray in the U.S. and Canada from Hikma Pharmaceuticals through a six-year agreement. This 8 mg naloxone product complements EBS's existing NARCAN® Nasal Spray 4 mg, expanding their portfolio of opioid overdose emergency treatments.
...
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Emergent BioSolutions (NYSE: EBS) has secured exclusive commercial rights to KLOXXADO® (naloxone HCl) Nasal Spray in the U.S. and Canada from Hikma Pharmaceuticals through a six-year agreement. This 8 mg naloxone product complements EBS's existing NARCAN® Nasal Spray 4 mg, expanding their portfolio of opioid overdose emergency treatments.
...
$Emergent BioSolutions (EBS.US)$ Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
2 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent's ability to distribute multiple life-saving opioid overdose emergency treatments to patients, customers and communities in need
Focus remains on increasing access, ra...
2 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent's ability to distribute multiple life-saving opioid overdose emergency treatments to patients, customers and communities in need
Focus remains on increasing access, ra...
1
$Tenaya Therapeutics (TNYA.US)$ Trial data on hypertrophic cardiomyopathy (HCM) at 8AM ET. Large float. SI 25.47%. COH $129.9M good for 16.2 months
$Biomea Fusion (BMEA.US)$ Covalent III Trial regarding Type 2 Diabetes mellitus out tomorrow 8AM ET. SI 44.16%. COH $62.4M good for 6.2 months
$Sidus Space (SIDU.US)$ Satellite launch Friday. May continue until launch. Low float. 0 shares LTB.COH $4.8M good for 4.2 months✅
$Maison Solutions (MSS.US)$ PR AH 12/...
$Biomea Fusion (BMEA.US)$ Covalent III Trial regarding Type 2 Diabetes mellitus out tomorrow 8AM ET. SI 44.16%. COH $62.4M good for 6.2 months
$Sidus Space (SIDU.US)$ Satellite launch Friday. May continue until launch. Low float. 0 shares LTB.COH $4.8M good for 4.2 months✅
$Maison Solutions (MSS.US)$ PR AH 12/...
40
3
11
$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions (NYSE: EBS) has received a $50 million contract option from BARDA for its CYFENDUS® anthrax vaccine. The deliveries are scheduled between now and April 2025. This follows a previous $30 million contract modification for the same vaccine. CYFENDUS®, FDA-approved in July 2023, is a two-dose anthrax vacci...
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions (NYSE: EBS) has received a $50 million contract option from BARDA for its CYFENDUS® anthrax vaccine. The deliveries are scheduled between now and April 2025. This follows a previous $30 million contract modification for the same vaccine. CYFENDUS®, FDA-approved in July 2023, is a two-dose anthrax vacci...
$Emergent BioSolutions (EBS.US)$ Reuters
Just
Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted
Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025
Just
Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted
Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025
$Emergent BioSolutions (EBS.US)$ 👈 this small float is the maker of narcan the drug that saves lives from opioid overdoses. Huge in the United States because of the cartels pushing fentanyl all over killing everyone.Hit them with narcan it's already saved countless lives. States are starting to require they have some on hand in schools. narcan will be sold all over in every pharmacy, sold to schools , jails, hospitals etc....only one thing like it but doesn't work on fentanyl like narcan does. N...
1
$Emergent BioSolutions (EBS.US)$ buying back in ... BlackRock, vanguard purposely push assets down. this company has far too many good things happening with new CEO turning things around starting past year. it's bottomed out earlier this year guess who are the ones pushing it down.... they are the ones wanting to buy in cheaper
$Synopsys (SNPS.US)$ $Futu Holdings Ltd (FUTU.US)$ $IonQ Inc (IONQ.US)$
$Synopsys (SNPS.US)$ $Futu Holdings Ltd (FUTU.US)$ $IonQ Inc (IONQ.US)$
8
$Emergent BioSolutions (EBS.US)$ why keep dipping??
1
No comment yet
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
HUANG AI : thanks for sharing
magickbeans710 : Thanks man
103567231 : Bro. I saw your post, noticed those colorful ones, but they have already started to skyrocket. I dare not buy. How did you get this information? We are all too late to Buy. Thank you.
Jaguar8 OP 103567231 : Whoever is telling you to buy anyway? It’s your decision and it’s MY WATCHLIST.
Jaguar8 OP 103567231 : Unfollow me and make your own watchlist.
View more comments...